Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis (Q74309230)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Giorgio Walter Canonica

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

G Passalacqua

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Albano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

L Fregonese

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C Pronzato

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

G S Mela

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

9103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

629-632

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500318%20AND%20SRC:MED&resulttype=core&format=json

A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907055-4

7 January 2021

A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907055-4

7 January 2021

Specific IgE, IgG, and IgA antibody response to oral immunotherapy in birch pollinosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907055-4

7 January 2021

A potential vaccine strategy for asthma and allied atopic diseases during early childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907055-4

7 January 2021

Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907055-4

7 January 2021

Allergic subjects express intercellular adhesion molecule--1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907055-4

7 January 2021

Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Relationships with early and late inflammatory phenomena

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907055-4

7 January 2021

Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907055-4

7 January 2021

Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907055-4

7 January 2021

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907055-4

7 January 2021

Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907055-4

7 January 2021

Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907055-4

7 January 2021

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907055-4

7 January 2021

10.1016/S0140-6736(97)07055-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500318%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference